ArticleMolecular cancer therapeutics2022

FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.

Peter M Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.